Shijiazhuang Yiling Pharma Raises Offering Price of ChiNext IPO

Shijiazhuang Yiling Pharmaceutical now expects to raise as much as 2.25 billion RMB ($348 million) in its ChiNext IPO. The latest offering price was increased by about one-third to 34.56 yuan, reflecting investor demand. Yiling, which plans to place 65 million shares, is primarily known as a TCM and nutraceutical company, though it has biological medicines in its portfolio and offers CRO services as well. More details.... Share this with colleagues:   var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});